Business Description
Q BioMed Inc
NAICS : 325412
SIC : 2834
ISIN : US74736N1054
Description
Q BioMed Inc is a biotech acceleration and commercial stage company. It is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure customers meet their developmental potential, enabling them to provide products to patients in need.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 1043.54 | |||||
OCF Margin % | 1043.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:QBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Q BioMed Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.209 | ||
| EPS (TTM) ($) | -0.084 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 1.47 | ||
| Volatility % | 50 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range ($) | 0.0001 - 0.02505 | ||
| Shares Outstanding (Mil) | 145.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Q BioMed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Q BioMed Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 2.5:1 Stock Split | 2015-08-07 | 1.31 (+0.00%) |
Show
Entries
Q BioMed Inc Frequently Asked Questions
What is Q BioMed Inc(QBIO)'s stock price today?
The current price of QBIO is $0.00. The 52 week high of QBIO is $0.03 and 52 week low is $0.00.
When is next earnings date of Q BioMed Inc(QBIO)?
The next earnings date of Q BioMed Inc(QBIO) is .
Does Q BioMed Inc(QBIO) pay dividends? If so, how much?
Q BioMed Inc(QBIO) does not pay dividend.
Guru Commentaries on OTCPK:QBIO
No articles.
Press Release
Articles on Q BioMed Inc
No articles.